Drawing for HEPSYN - B

USPTO serial 79137769

HEPSYN - B

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
BLANE, SUZANNE
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HEPSYN - B?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances, namely, pharmaceuticals for use in the treatment of hepatitis B; vaccines; pharmaceuticals for immunotherapies to treat immune system diseases and disordersABANDONED—
042Medical research and development; research and development of vaccines and immunotherapies; synthesising vaccinesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 7, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Jan 6, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Dec 4, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 25, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 31, 2016FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 11, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 9, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 9, 2015MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Jan 9, 2015ABN5ABANDONMENT - AFTER PUBLICATION—
Jan 7, 2015EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Aug 20, 2014ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 29, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 24, 2014GPNXNOTIFICATION PROCESSED BY IB—
Jul 9, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 9, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 9, 2014NPUBNOTICE OF PUBLICATION—
Jun 23, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 23, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 9, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 9, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 23, 2014ALIEASSIGNED TO LIE—
May 12, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 12, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 10, 2013RFNTREFUSAL PROCESSED BY IB—
Nov 20, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 20, 2013RFRRREFUSAL PROCESSED BY MPU—
Nov 17, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 16, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 12, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 6, 2013DOCKASSIGNED TO EXAMINER—
Nov 6, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 1, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance